Method: Perform Western blotting using cell lysates with known SCC4 expression levels (e.g., HeLa, MCF7) and include negative controls (knockdown or knockout cell lines). Compare observed molecular weight (~66–69 kDa) to predicted size (69 kDa) .
Troubleshooting: Non-specific bands may arise due to cross-reactivity. Pre-absorb antibody with antigen-blocking peptides or use siRNA-mediated SCC4 knockdown to confirm specificity .
Protocol: Crosslink cells with 1% formaldehyde, sonicate chromatin to 200–500 bp fragments, and use 1–2 μg antibody per IP. Validate enrichment at cohesin-loading sites (e.g., centromeres) via qPCR .
Critical Controls: Include IgG isotype controls and target-negative genomic regions to assess background signal .
Approach: Combine RNA-seq (to assess transcriptional changes) with cohesin ChIP-seq in SCC4-depleted cells. Prioritize systems where SCC4’s dual roles are context-dependent (e.g., bacterial models vs. mammalian cells) .
Strategy: Use synchronized cell populations (e.g., double thymidine block) and perform immunofluorescence (IF) with anti-SCC4 antibody [EPR14390] at 1:100 dilution. Co-stain with cell cycle markers (e.g., Cyclin B1 for G2/M) .
Data Interpretation: Note that SCC4 may dissociate from chromatin during mitosis, necessitating careful fixation/permeabilization (e.g., 0.1% Triton X-100) .
Co-IP Workflow:
Experimental Design:
Gene Expression vs. Cohesin Loading: To isolate SCC4’s transcriptional role (e.g., σ 66 RNAP interaction), use bacterial systems (E. coli) with IPTG-inducible SCC4 expression . For cohesin studies, employ mammalian cells with auxin-inducible SCC4 degradation .
Quantitative Analysis: Normalize SCC4 ChIP-seq data to input DNA and use spike-in controls (e.g., Drosophila chromatin) for cross-experiment comparisons .